Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

Name: Switzerland Diabetes Market, Size, Forecast 2023-2028
Creator: Renub Research
License: https://www.renub.com/privacy-policy-13-a.php
Keywords: Switzerland Diabetes Market

Buy Now

Excel: 8 Hours

PDF: 24 Hours

Mar 2023

Pages: 190

Switzerland Diabetes Market Outlook

Switzerland Diabetes Market will reach US$ 1.99 Billion at a CAGR of 4.71% by 2028, according to Renub Research. Almost half a million people in Switzerland have diabetes, which is constantly rising. Diabetes is an essential public health paging, one of four priority non-infectious diseases targeted for action by world leaders. The prevalence of Swiss Diabetes has been steadily increasing over the past few decades. Due to population boost, urbanization, aging, and the rising prevalence of obesity, the number of individuals with Diabetes is growing. Improving glycemic control is associated with reducing late complications of Diabetes, such as cardiovascular and micro vascular diseases. Therefore, treatment guidelines were established internationally by prominent and renowned associations and adopted by many countries.

Type 2 Diabetes is Increasing Year on Year

In Switzerland, Diabetes affects approximately 5% of the population; type 2 diabetes, the most common type, affects about 500,000 people, while type 1 diabetes affects about 40,000 people, according to the Swiss Medical Net. Diabetes can lead to complications in many body parts and increase the risk of dying prematurely. Possible complications include kidney failure, leg amputation, heart attack, stroke, nerve damage, and vision loss.

In addition, patients with T2D must have a BMI of ≥ 28 kg/m2 for health insurance to reimburse semaglutide treatment. This may have had implications for the patients enrolled in SURE Switzerland. According to our research study Diabetes Market in Switzerland was valued at US$ 1.51 Billion in 2022.

Increasing Number of Diabetes in Switzerland will create more demand for Insulin Pen Market

Based on devices, Switzerland Diabetes Market is classified into four types: Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), and Insulin Pump and Insulin Pens. Insulin pens will hold the maximum share during the upcoming years due to the rising prevalence of Diabetes in various age groups; increasing R&D activities also boost the insulin pen market. Currently, over 95% of the insulin used in Switzerland is sold in a concentration of 40 units per ml. However, only recently, a small but increasing amount of more concentrated insulin has been introduced through "pen" injectors designed for U-100 (= 100 units per ml) insulin.

With the greater ease of use of insulin pens, people in Switzerland with visual impairment or reduced dexterity may significantly benefit from using an insulin pen rather than a vial and syringe. However, once in use, most insulin analog vials, cartridges, and prefilled pens must be discarded after 28 days. Moreover, SMBG, Insulin Pumps, and CMG will also grow in Switzerland during the upcoming year. The Insulin Pump is especially suitable for patients with type-1 Diabetes who require a continuous supply of insulin and need to balance every meal with additional insulin.

Switzerland Health Policy

The Swiss healthcare system's duties and responsibilities are divided among cantonal, federal and municipal governments. Each of the 26 cantons was responsible for licensing providers, coordinating hospital services, promoting health through disease prevention, and subsidizing institutions and individual premiums. The federal government regulates system financing, ensures the safety and quality of pharmaceuticals and medical devices, oversees public health initiatives, and promotes research and training. The municipalities organize and provide long-term care (nursing home care and home care services) and other social support services for vulnerable groups.

Key Company

The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Sanofi, Eli Lilly and Company, Becton Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Biocon, Medtronic, Insulet Corporation, Abbott Laboratories, Terumo Corporation, and Dexcom Inc.

In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.

Renub Research report titled “Switzerland Diabetes Market & Forecast, By Continuous Glucose Monitoring Analysis (Glucose Sensor Market &Forecast, CGM Transmitter Market& Forecast, CGM User, and CGM Reimbursement), Self-Monitoring Blood GlucoseAnalysis(Test Strips Market& Forecast, Lancet Market & Forecast, Meter Market and Forecast, Blood Glucose (SMBG) Users and Blood Glucose Devices Reimbursement), Insulin Pen Analysis (Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, insulin Pen Needle Market, insulin Pen Users, and reimbursement Policies), Insulin Pump Analysis (Insulin Pump Market, Insulin Pump Users, Insulin Pump Products and Reimbursement), Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Switzerland Diabetes Market.

Switzerland Segments Market based on Devices

Segments Market based on Devices

1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump

Switzerland Diabetes Sub-Segment Analysis

1. Continuous Glucose Monitoring (CGM)

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement

2. SMBG

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement

3. Insulin Pen Market

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies

4. Insulin Pump Market

1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies

All the 13 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. Insulet Cororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care

Report Details:

Report Features	Details
Base Year	2022
Historical Period	2017 - 2022
Forecast Period	2023 - 2028
Market	US$ Billion
Segment Covered	CGM, SMBG, Insulin Pump, and Insulin Pen
Companies Covered	B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care
Customization Scope	20% Free Customization
Post-Sale Analyst Support	1 Year (52 Weeks)
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

Key Benefits of the Report

This report provides current market estimates and forecasts for Switzerland Diabetic Market.
Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
Detailed analysis of Switzerland SMBG Market.
Detailed analysis of Switzerland CGM Market.
Detailed analysis of Switzerland Insulin Pump Market.
Detailed analysis of Switzerland Insulin Pen Market.
Switzerland Diabetic Market – Growth Drivers and Challenges.
Key sustainability strategies adopted by market players.

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges

5. Switzerland Diabetes Market

6. Switzerland Diabetes Population

6.1 Type 1 Diabetes
6.2 Type 2 Diabetes

7. Switzerland Diabetes Market Share Analysis

7.1 By Types

8. Continuous Glucose Monitoring Market (CGM) – Market & Users

8.1 Switzerland - CGM Market by Components

8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market

8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Switzerland

9. Blood Glucose Device (SMBG) – Switzerland Market & Users

9.1 Market

9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market

9.2 Test Strips Market

9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes

9.3 Lancet Market

9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes

9.4 Meter Market and Forecast

9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes

9.6 Reimbursement Policies of Blood Glucose Devices in Switzerland

10. Insulin Pen – Switzerland Market & User Analysis

10.1 Insulin Pen Market

10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market

10.2 Insulin Pen Needle Market

10.3 Insulin Pen User

10.3.1 Disposable Insulin Pen User
10.3.2 Reusable Insulin Pen User
10.3.3 Smart Insulin Pen User

10.4 Reimbursement Policies of Insulin Pen in Switzerland

11. Insulin Pump - Switzerland Market & Users

11.1 Insulin Pump Market

11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market

11.2 Insulin Pump User

11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User

11.3 Differentiation Points of Insulin Pump Products in Switzerland

12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue

12.3 Terumo Corporation

12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue

12.6 Ypsomed AG

12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue

13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue

14. SMBG – Company Analysis

14.1 DarioHealth Corp

14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue

14.2 Abbott Laboratories

14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue

15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue

15.2 Roche

15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue

15.3 Tandem Diabetes Care

15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue

List of Figures:

Figure-01:   Switzerland – Diabetes Market (Billion US$), 2017 – 2022
Figure-02:   Switzerland – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03:   Switzerland – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04:   Switzerland – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05:   Switzerland – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06:   Switzerland – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07:   Switzerland – Glucose Sensor Market (Million US$), 2017 – 2023
Figure-08:   Switzerland – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
Figure-09:   Switzerland – CGM Transmitter Market (Million US$), 2017 – 2023
Figure-10:   Switzerland – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
Figure-11:   Switzerland – CGM User (Number), 2017 – 2023
Figure-12:   Switzerland – Forecast for CGM User (Number), 2023 – 2028
Figure-13:   Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14:   Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15:   Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16:   Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17:   Switzerland – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18:   Switzerland – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19:   Switzerland – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20:   Switzerland – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21:   Switzerland – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22:   Switzerland – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23:   Switzerland – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24:   Switzerland – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25:   Switzerland – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26:   Switzerland – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27:   Switzerland – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28:   Switzerland – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29:   Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30:   Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31:   Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32:   Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33:   Switzerland – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34:   Switzerland – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35:   Switzerland – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36:   Switzerland – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37:   Switzerland – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38:   Switzerland – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-45:   Switzerland – Insulin Pen Needle Market (Million US$), 2017 – 2023
Figure-46:   Switzerland – Forecast for Pen Needle Market (Million US$), 2023 – 2028
Figure-39:   Switzerland – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40:   Switzerland – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41:   Switzerland – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42:   Switzerland – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43:   Switzerland – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44:   Switzerland – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-47:   Switzerland – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48:   Switzerland – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49:   Switzerland – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50:   Switzerland – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51:   Switzerland – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52:   Switzerland – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53:   Switzerland – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54:   Switzerland – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55:   B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56:   B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57:   Eli Lilly – Global Revenue (Million US$), 2017 – 2022
Figure-58:   Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-59:   Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60:   Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61:   BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62:   BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63:   Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
Figure-64:   Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-65:   Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
Figure-66:   Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-67:   Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68:   Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69:   Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-70:   Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-71:   DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
Figure-72:   DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-73:   Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74:   Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75:   Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76:   Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77:   Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78:   Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79:   Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
Figure-80:   Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables:

Table-01: Switzerland – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Switzerland – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

Get Sample

Request Sample

Request Customization

Reach out to us

Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822

Drop us an email at
info@renub.com